Clinical Trials Browser

Recruiting × Neuroblastoma × Drug Therapy × Clear all

NCT06933394 2025-04-18

Arsenic Trioxide With MAPK Inhibitors and Chemotherapy for Stage 4/M Neuroblastoma

Phase 2 Recruiting

Neuroblastoma